Latest filing published 25 Mar 2026 for IMPACT BIOMEDICAL INC., €28k.
No signal scores available.
This profile gathers the share dealings of Jason Grady across 2 companies, led by DSS, Inc. and Impact Biomedical Inc. Over a trading history stretching from 23 July 2019 to 23 March 2026, the count stands at 2 filings.
Sales make up the whole of the open-market record (1 sale, €28k). Besides market trades, the filings include 1 share grant. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 25 March 2026, the filings show an open-market sale worth €28k in Impact Biomedical Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations